Stakeholder News | Global HIV Vaccine Enterprise

News about the Enterprise's Stakeholders.

AVAC Calls for AIDS Vaccine Field to Implement New Scientific Strategic Plan Released by Global HIV Vaccine Enterprise - September 7, 2010

AVAC released a statement welcoming the new Global HIV Vaccine Enterprise Scientific Strategic Plan stating that the Plan is "a critical document that the field must implement as part of ongoing efforts to improve coordination, efficiency and transparency to quickly capitalize on recent advances in AIDS vaccine research." The full statement is below.

1 attachment

AVAC Calls for Speedy Funding of Critical Microbicide Follow-Up Studies - September 3, 2010

AVAC today issues a call to action to donors, policy-makers, researchers and advocates to ensure that critical follow-up studies to the landmark CAPRISA 004 microbicide trial receive the economic and political support needed to move forward as quickly as possible. The call comes as a group of microbicide and public health experts have agreed upon a plan for further studies, which are expected to cost $100 million over three years, of which only $58 million has been committed. See below for full announcement.

1 attachment

UNAIDS Statement - Road-map agreed for confirmatory trials of promising microbicide - September 3, 2010

Gates Foundation Launches RFP to Diversify Pipeline of Product Concepts for an HIV Vaccine within CAVD - August 25, 2010

The Bill & Melinda Gates Foundation is launching a Request for Proposals (RFP) to address four topic areas in order to diversify the pipeline of product concepts for an HIV vaccine within the Collaboration for AIDS Vaccine Discovery (CAVD) initiative.

Advances on HIV Prevention Tools Heralded At Conference - July 23, 2010

The International AIDS Vaccine Initiative (IAVI) issued a statement on advances on HIV prevention tools at the International AIDS Conference in Vienna. The full statement is below.

1 attachment

Update on the Renewed Canadian HIV Vaccine Initiative - July 21, 2010

The Honourable Leona Aglukkaq, Minister of Health in collaboration with the Bill & Melinda Gates Foundation, announced the renewed Canadian HIV Vaccine Initiative (CHVI), which features the creation of the CHVI Research and Development Alliance. The full announcement is available here: http://www.chvi-icvv.gc.ca/index-eng.html.

Statement of Anthony S. Fauci, M.D., on Results from the CAPRISA 004 Microbicide Study - July 20, 2010

The National Institute of Allergy and Infectious Diseases National Institutes of Health congratulate the Centre for the AIDS Program

WHO and UNAIDS Welcome Ground Breaking Proof Of Concept Study Results For Vaginal Gel Showing Reduced Risk of HIV Infections In Women - July 20, 2010

WHO and UNAIDS congratulate CAPRISA, a designated UNAIDS Collaborating Centre for HIV Prevention Research, on the successful completion of the study. The full statement is available here: http://www.unaids.org/en/KnowledgeCentre/Resources/PressCentre/PressReleases/2010/20100719_PS.asp.

Statement of Larry Corey, MD on the Success of the CAPRISA 004 Microbicide Trial - July 19, 2010

The HIV Vaccine Trials Network (HVTN) issued a statement on the CAPRISA 004 microbicide trial. The full statement is below.

1 attachment

Study of Microbicide Gel Shows Reduced Risk of HIV & Herpes Infections in Women - July 19, 2010

The Centre for the AIDS Programme of Research in South Africa (CAPRISA) reports that researchers have achieved an important scientific breakthrough in the fight against HIV and genital herpes with a vaginal gel that significantly reduces a woman's risk of being infected with these viruses.&